NVAXNOVAVAX INC

Nasdaq novavax.com


$ 20.95 $ 3.21 (18.07 %)    

Wednesday, 05-Jun-2024 15:59:58 EDT
QQQ $ 454.82 $ 9.16 (2.02 %)
DIA $ 398.57 $ 1.02 (0.26 %)
SPY $ 530.36 $ 6.28 (1.19 %)
TLT $ 91.26 $ 0.68 (0.73 %)
GLD $ 225.37 $ 2.55 (1.18 %)
$ 20.97
$ 17.91
$ 0.00 x 0
$ 0.00 x 0
$ 17.83 - $ 22.21
$ 3.53 - $ 22.24
41,816,446
na
2.93B
$ 0.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-10-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-28-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-01-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-11-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-07-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 03-18-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-08-2017 03-31-2017 10-Q
30 02-27-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Bloomberg

Core News & Articles

- Bloomberg

Core News & Articles

- Reuters

 whats-going-on-with-novavax-stock

Novavax, Inc. shares are trading higher Wednesday, and the stock is up by more than 300% over the past month. Here's a look...

 novavax-says-jn1-vaccine-generates-broad-neutralizing-responses-for-jn1--lineage-subvariants-in-non-clinical-models

- Reuters 

Core News & Articles

https://www.youtube.com/watch?v=qCsEbq9SpsM 

Core News & Articles

- Reuters - Reuters 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION